Skip to main content

Advertisement

SpringerLink
Log in

High Risk of Colostomy with Primary Radiotherapy for Anal Cancer

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Radiotherapy (RT) has become the primary treatment of choice for anal cancer in an effort to avoid colostomy. The current role of surgery appears generally to be underestimated, since diverting colostomy or abdominoperineal resection still often seems to be necessary for complications and local treatment failure after RT.

Methods

The data of 83 patients primarily treated by RT with curative intent throughout a 20-year period in our institute were analyzed regarding the need for colostomy.

Results

Totally, 28 patients (34%) required creation of a colostomy after primary RT for local failure or treatment-related complications during a mean follow-up period of 39 months. The 3-year actuarial colostomy-free rate was 59% (mean 85 ± 9 months). Early stage disease, low T-score and absence of infiltration in adjacent organs were associated with a reduced need for colostomy in univariate analysis. In multivariate analysis only T-score was an independent variable in predicting prolonged colostomy-free interval. In this study, no statistically significant differences were noted for gender, age, nodal status, total radiation dose, radiation boost and concurrent chemotherapy.

Conclusions

In approximately one-third of the patients treated by anal sphincter saving management with curative aimed primary RT, the creation of a colostomy appeared to be necessary for RT complications and local treatment failure. Therefore, patients should be well informed regarding the considerable risk of need for colostomy after RT for anal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.

Similar content being viewed by others

References

  1. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 2004; 101:281–8

    Article  PubMed  Google Scholar 

  2. Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol 2004; 5:149–57

    Article  PubMed  Google Scholar 

  3. Allal AS, Sprangers MA, Laurencet F, Reymond MA, Kurtz JM. Assessment of long-term quality of life with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer 1999; 80:1588–94

    Article  PubMed  CAS  Google Scholar 

  4. Vordermark D, Sailer M, Flentje M, Thiebe A, Kölbl O. Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 1999; 52:239–43

    Article  PubMed  CAS  Google Scholar 

  5. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 173:354–6

    Article  Google Scholar 

  6. UKCCCR Anal cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996; 348:1049–54

    Article  Google Scholar 

  7. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15:2040–9

    PubMed  CAS  Google Scholar 

  8. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive non surgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996; 14:2517–39

    Google Scholar 

  9. Allal AS, Obradovic M, Laurencet F, Roth AD, Spada A, Marti M-C, Kurtz JM. Treatment of anal carcinoma in the elderly. Feasibility and outcome of radical radiotherapy with or without concomitant chemotherapy. Cancer 1999; 85:26–31

    Article  PubMed  CAS  Google Scholar 

  10. Chauvenic L, Buthaud X, Falcou MC, De la Rochefordiere A, Pierga JY, Girodet J, Salmon RJ. Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy. Br J Cancer 2003; 89:2057–61

    Article  Google Scholar 

  11. Klas JV, Rothenberger DA, Wong WD, Madoff RD. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer 1999; 85:1686–93

    Article  PubMed  CAS  Google Scholar 

  12. Peiffert D, Bey P, Pernot M, et al. Conservative treatment by irradiation of epidermoid cancer of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 1997; 37:313–24

    Article  PubMed  CAS  Google Scholar 

  13. Friberg B, Svensson C, Goldman S, Glimelius B. The Swedish National Care Programme for anal carcinoma. Implementation and overall results. Acta Oncol 1998; 37:25–32

    Article  PubMed  CAS  Google Scholar 

  14. Gerard J-P, Chapet O, Samiei F, et al. Management of inguinal node metastases in patients with carcinoma of the anal canal. Experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001; 92:77–84

    Article  PubMed  CAS  Google Scholar 

  15. Deniaud-Alexandre E, Touboul E, Tiret E, et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 2003; 56:1259–73

    Article  PubMed  Google Scholar 

  16. Cummings BJ, Keane TJ, O’Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiotherapy alone or by radiation and 5-fluorouracil with and without mitomycin-C. Int J Radiat Oncol Biol Phys 1991; 21:1115–25

    PubMed  CAS  Google Scholar 

  17. Renehan AG, Saunders MP, Schofield PF, O’Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. J Br Surg 2005; 92:605–14

    Article  CAS  Google Scholar 

  18. Wagner J-P, Mahe MA, Romestaing P, Rocher FP, Berger C, Trillet-Lenoir V, Gerard J-P. Radiation therapy in the conservative treatment of carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1994; 29:17–23

    PubMed  CAS  Google Scholar 

  19. Allal A, Kurtz JM, Pipard G, Marti M-C, Miralbell R, Popowski Y, Egeli R. Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys 1993; 27:59–66

    PubMed  CAS  Google Scholar 

  20. Allal SM, Mermillod B, Roth AD, Marti M-C, Kurtz JM. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 1997; 39:1099–105

    Article  PubMed  CAS  Google Scholar 

  21. Nilsson PJ, Svensson C, Goldman, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002; 89:1425–9

  22. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti M-C. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999; 86:405–9

    Article  PubMed  CAS  Google Scholar 

  23. Sandhu APS, Symonds RP, Robertson AG, Reed NS, McNee SG, Paul J. Interstitial iridium-192 implantation combined with external radiotherapy in anal cancer: a 10-years experience. Int J Radiat Oncol Biol Phys 1998; 40:575–81

    Article  PubMed  CAS  Google Scholar 

  24. Feringo R, Nakamura RA, Dos Santos Novaes PER, et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 2005; 61:1136–42

    Article  Google Scholar 

  25. Gerard J-P, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet J-M, Mornex F. Treatment of anal canal carcinoma with high dose radiation and concomitant fluorouracil-cisplatin. Long-term results in 95 patients. Radiother Oncol 1998; 46:249–56

    Article  PubMed  CAS  Google Scholar 

  26. Allal SM, Mermillod B, Roth AD, Marti M-C, Kurtz JM. Impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy. Cancer 1997; 79:2329–35

    Article  PubMed  CAS  Google Scholar 

  27. Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998; 41:1488–93

    Article  PubMed  CAS  Google Scholar 

  28. van der Wal BCH, Cleffken BI, Gulec B, Kaufman HS, Choti MA. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg 2001; 5:383–7

    Article  PubMed  Google Scholar 

  29. Ellenhorn JD, Enker WE, Quan SH. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid of the anus. Ann Surg Oncol 1994; 1:105–10

    Article  PubMed  CAS  Google Scholar 

  30. Charnley N, Choudhury A, Chesser P, Cooper RA, Sebag-Montefiore D. Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy. Br J Cancer 2005; 92:1221–5

    Article  PubMed  CAS  Google Scholar 

  31. Milano MT, Jani AB, Farrey KJ, Rash C, Heimann R, Chmura SJ. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005; 63:354–61

    Article  PubMed  Google Scholar 

  32. Putta S, Andreyev HJ. Faecal incontinence: a late side-effect of pelvic radiotherapy. Clin Oncol (R Coll Radiol) 2005; 17:469–77

    CAS  Google Scholar 

  33. Grabenbauer GG, Matzel KE, Schneider IH, et al. Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases. Dis Colon Rectum 1998; 41:411–50

    Article  Google Scholar 

  34. Peiffert D, Giovannini M, Ducreux M, et al. High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study. Ann Oncol 2001; 12:397–404

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands

    Eelco de Bree MD, Serge van Ruth MD, PhD & Frans A. N. Zoetmulder MD, PhD

  2. Department of Radiotherapy, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands

    Luc G. H. Dewit MD

  3. Department of Surgical Oncology, University Hospital, P.O. Box 1352, 7111 10, Herakleion, Greece

    Eelco de Bree MD

Authors
  1. Eelco de Bree MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serge van Ruth MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luc G. H. Dewit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frans A. N. Zoetmulder MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eelco de Bree MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Bree, E., van Ruth, S., Dewit, L.G.H. et al. High Risk of Colostomy with Primary Radiotherapy for Anal Cancer. Ann Surg Oncol 14, 100–108 (2007). https://doi.org/10.1245/s10434-006-9118-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9118-5

Keywords

Search

Navigation